From the Saporta Report:

Emory University’s pioneering work with a class of small molecules known as JAK (janus kinase) inhibitors continues to generate interest into how HIV might be cured after a second patient who received the treatment was declared to be in long-term remission.  The use of JAK inhibitors against HIV began with a ground-breaking discovery led by Christina […]

The post Emory research connected to second patient in sustained remission of HIV appeared first on SaportaReport.